发明公开
US20240252731A1 A Secondary Plasma Device for Collection of Cell-free Nucleic Acids from Blood Plasma During Extracorporeal Blood Processing by Clinical Apheresis Machines
审中-公开
![A Secondary Plasma Device for Collection of Cell-free Nucleic Acids from Blood Plasma During Extracorporeal Blood Processing by Clinical Apheresis Machines](/abs-image/US/2024/08/01/US20240252731A1/abs.jpg.150x150.jpg)
基本信息:
- 专利标题: A Secondary Plasma Device for Collection of Cell-free Nucleic Acids from Blood Plasma During Extracorporeal Blood Processing by Clinical Apheresis Machines
- 申请号:US18563977 申请日:2022-05-24
- 公开(公告)号:US20240252731A1 公开(公告)日:2024-08-01
- 发明人: Mark Brenneman
- 申请人: MESA ALTA RESEARCH, LLC
- 申请人地址: US NM Albuquerque
- 专利权人: MESA ALTA RESEARCH, LLC
- 当前专利权人: MESA ALTA RESEARCH, LLC
- 当前专利权人地址: US NM Albuquerque
- 国际申请: PCT/US22/30761 2022.05.24
- 进入国家日期: 2023-11-24
- 主分类号: A61M1/34
- IPC分类号: A61M1/34 ; A61M1/36 ; C12N15/10
摘要:
A secondary plasma device (SPD) and methods for its use with apheresis machines or similar extracorporeal blood processing systems and capable of collecting cell-free nucleic acids (cfNA) directly from a subject's circulating plasma, the SPD comprising:
i. a sterile capsule having an inlet port and an outlet port and enclosing a filtration/adsorption medium, and configured to receive plasma from the extracorporeal blood processing circuit through the inlet port, such that plasma enters under pressure and flows through the filtration/adsorption medium then exits through the outlet port to a return path of the extracorporeal blood processing circuit leading back to the subject; and
ii. the filtration/adsorption medium bearing fixed positive charge that captures cfNA from plasma by anion exchange, and from which cfNA can be subsequently recovered in quantities 10 to 1000-fold greater than the amount of cfNA contained in a 5 ml venipuncture specimen of the subject's blood.
i. a sterile capsule having an inlet port and an outlet port and enclosing a filtration/adsorption medium, and configured to receive plasma from the extracorporeal blood processing circuit through the inlet port, such that plasma enters under pressure and flows through the filtration/adsorption medium then exits through the outlet port to a return path of the extracorporeal blood processing circuit leading back to the subject; and
ii. the filtration/adsorption medium bearing fixed positive charge that captures cfNA from plasma by anion exchange, and from which cfNA can be subsequently recovered in quantities 10 to 1000-fold greater than the amount of cfNA contained in a 5 ml venipuncture specimen of the subject's blood.